• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Russell Cohen, MD, Discusses Medication Adherence in Inflammatory Bowel Disease

Article

Russell Cohen, MD, says medication adherence is an important issue for inflammatory bowel disease (IBD), because patients must stay on medications long term. Dr Cohen comments, "IBD is a chronic relapsing condition, you don't just stop your medicines."

Russell Cohen, MD, says medication adherence is an important issue for inflammatory bowel disease (IBD), because patients must stay on medications long term. Dr Cohen comments, "IBD is a chronic relapsing condition, you don't just stop your medicines." There have been many breakthroughs in medication adherence for managing IBD. For instance, Dr Cohen says once-a-day dosing ensures patients don't fall behind in taking their prescribed medications.

This video was taken on May 2, 2013, at the NAMCP Spring Managed Care Forum in Orlando, FL.

Related Videos
Screenshot of an interview with Nicolas Girard, MD, PhD
Byoung Chul Cho, MD, PhD
Efren Flores, MD
Dr Deepak Bhatt
The 2025 ASPC Congress on CVD Prevention
Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, Mount Sinai Fuster Heart Hospital
Saad Z. Usmani, MD, MBA, FACP, FASCO, MSKCC
Rakendu Rajendran, MBBS
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.